Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Assets (2016 - 2025)

Apyx Medical (APYX) has disclosed Assets for 16 consecutive years, with $66.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets rose 3.08% year-over-year to $66.8 million, compared with a TTM value of $66.8 million through Dec 2025, up 3.08%, and an annual FY2025 reading of $66.8 million, up 3.08% over the prior year.
  • Assets was $66.8 million for Q4 2025 at Apyx Medical, up from $57.4 million in the prior quarter.
  • Across five years, Assets topped out at $79.2 million in Q4 2023 and bottomed at $51.8 million in Q4 2022.
  • Average Assets over 5 years is $63.4 million, with a median of $62.7 million recorded in 2022.
  • The sharpest move saw Assets decreased 24.66% in 2022, then skyrocketed 53.05% in 2023.
  • Year by year, Assets stood at $68.7 million in 2021, then fell by 24.66% to $51.8 million in 2022, then surged by 53.05% to $79.2 million in 2023, then decreased by 18.17% to $64.8 million in 2024, then grew by 3.08% to $66.8 million in 2025.
  • Business Quant data shows Assets for APYX at $66.8 million in Q4 2025, $57.4 million in Q3 2025, and $58.2 million in Q2 2025.